Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

H. B. Fuller Company FUL

Basic Materials — Specialty Chemicals
Dividend Aristocrat Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years ,
Insider Buys alert about insiders buying in the last 12 month

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total buys
0.36
Total sells
1.86
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — 2 — — — — —
Sell 1 1 — — — — — — — — 1 —
Insider Ownership
1.54%

Capital & Financial Ratios

Market Cap
2,710.00
Revenue
3,507.95
Net Income
185.81
Free Cash Flow
148.77
Net Debt
1,958.05
Current Ratio
1.80
Debt/Equity
1.00
P/E ratio
17.09
P/S ratio
0.78
P/B ratio
1.32
Past 5Y EPS Growth
(1.78%)
This Y EPS Growth
14.43%
Next Y EPS Growth
9.59%
Next 5Y EPS Growth
12.50%
in millions of $

Dividends

Payout Ratio
0.30
Annual Dividend Rate
0.79
Annual Dividend Yield
1.11%
total individual payouts
2028 ‡‡‡‡‡
2027 ‡‡‡‡‡
2026 0.98
—
—
—
2025 0.93
—
—
—
—
2024 0.87
—
—
—
—
2023 0.81
—
—
—
—
2022 0.74
—
—
—
—
2021 0.67
—
—
—
—
2020 0.65
—
—
—
—
2019 0.64
—
—
—
—
2018 0.62
—
—
—
—
2017 0.59
—
—
—
—
2016 0.55
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 179.45 169.35 107.21 114.10
Receivables 577.93 558.34 564.34 622.75
Inventory 442.04 467.50 471.96 526.74
Other 112.68 104.02 119.75 135.84
1,312.10 1,299.21 1,263.27 1,399.42
2023 2024 2025 Q'26
Payables 439.70 491.44 470.13 526.32
ST’ Debt — — — —
Other — — — —
692.81 719.29 743.36 779.06
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Feb May Aug Nov Year
’26 770.84 950.27 — —
—
’25 788.66 898.10 892.04 894.79
3,473.59
’24 810.42 917.11 917.93 923.28
3,568.74
’23 809.18 898.24 900.63 902.88
3,510.93
’22 856.48 993.26 941.23 958.21
3,749.18
’21 725.90 827.87 826.83 897.42
3,278.03
’20 646.56 674.60 691.46 777.64
2,790.27
in millions of $

Operating Cash Flow

Feb May Aug Nov Year
’26 (3.97) 121.14 — —
—
’25 (52.91) 110.68 98.99 106.74
263.49
’24 47.35 81.62 87.81 85.65
302.44
’23 5.55 102.85 108.30 161.70
378.40
’22 (17.67) 8.54 57.83 207.82
256.51
’21 35.85 43.98 81.30 52.18
213.32
’20 34.43 73.99 84.62 138.53
331.56
in millions of $

Free Cash Flow

Feb May Aug Nov Year
’26 (61.35) 78.55 — —
—
’25 (85.41) 80.09 68.33 63.24
126.24
’24 4.63 34.86 65.55 59.32
164.35
’23 (41.45) 69.89 82.96 152.88
264.29
’22 (66.53) (10.38) 28.54 176.48
128.11
’21 0.83 29.51 56.31 33.48
120.12
’20 (0.18) 51.48 65.58 123.28
240.15
in millions of $

EPS

Feb May Aug Nov Year
’26 0.38 1.23 — —
—
’25 0.24 0.76 — 0.54
2.75
’24 0.55 0.91 0.98 (0.13)
2.30
’23 0.39 0.73 0.67 0.80
2.59
’22 0.69 0.86 0.84 0.87
3.26
’21 0.56 0.90 0.58 1.18
3.23
’20 0.19 0.61 0.79 0.77
2.36

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

1.7
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ 57.36 62.57 66.46 47.56 — — —
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 81.55 83.64 87.67 65.46 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7,000 7,200 7,500 7,100 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.54 0.49 0.48 0.49 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,749.18 3,510.93 3,568.74 3,473.59 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 25.70% 28.74% 29.75% 31.11% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 251.93 234.16 182.66 215.42 — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 6.72% 6.67% 5.12% 6.20% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 180.41 144.99 130.40 152.07 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 146.98 159.84 174.71 178.32 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 69.97 64.62 64.97 63.62 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 3.37 2.67 2.37 2.78 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.79 6.96 5.51 4.83 — — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (2.40) (2.10) (2.51) (2.51) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.39 4.86 2.99 2.31 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 30.06 32.32 33.31 36.69 ‡‡‡‡‡ — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 53.58 54.33 54.93 54.60 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 23.83 28.45 32.34 40.88 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.15 1.17 1.18 0.92 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.67 2.34 2.31 1.59 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.60 1.65 1.70 1.47 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 46.82 21.88 37.00 40.52 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 256.51 378.40 302.44 263.49 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (128.41) (114.11) (138.09) (137.25) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 128.11 264.29 164.35 126.24 ‡‡‡‡‡ — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 593.64 619.29 579.92 519.91 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,775.26 1,836.59 2,010.05 2,016.94 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,695.35 1,657.14 1,840.70 1,909.72 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,610.79 1,755.91 1,829.85 2,003.19 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.13% 3.15% 2.70% 3.00% ‡‡‡‡‡ — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 6.10% 6.50% 5.93% 5.67% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11.24% 8.61% 7.27% 7.93% ‡‡‡‡‡ — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

H.B. Fuller Company (FUL), a global adhesives leader, has delivered resilient revenue growth from $2.09 billion in 2016 to $3.57 billion in 2024 (7.1% CAGR), fueled by strategic acquisitions like Royal Adhesives and operational efficiencies, though a projected 2025 dip to $3.47 billion reflects cyclical softness in construction and packaging. Stock volatility mirrors economic swings—peaking at $87.67 in 2024 after a 2020 COVID low of $23.68—but shares now offer modest upside to analyst targets (7% mean, up to 24% high), with improving margins and earnings signaling value for patient investors despite net insider selling.

Profitability is strengthening, with gross margins expanding to 29.75% in 2024 and 31% projected in 2025, driving EPS from $2.48 to a forecasted $4.51 by 2028 (36% growth) and ROE doubling to nearly 19%. Balance sheet deleveraging post-acquisitions, ample working capital, and FCF recovery to $250 million by 2026 support dividends, buybacks, and M&A, while trading at a forward P/E of 20x and EV/Sales of 1.47x implies a 10-15% discount to peers.

Analysts forecast 19% EPS CAGR through 2028 amid end-market rebounds in hygiene, electronics, and renewables, with DCF models pointing to 15-20% intrinsic upside. Balancing cyclical risks like inflation and geopolitics with structural tailwinds like specialty adhesives and digital transformation, FUL appears poised for 10-15% annualized returns—read the full analysis for detailed correlations, forecasts, and catalysts.

Read full commentary →

H. B. Fuller Company (FUL) Latest News

News by impact score

Fine-tune

6 Sep

4 , 4:46 PM
H.B. Fuller rejected Ancora's $1.2 billion acquisition offer, declaring the bid insufficient and undervaluing the company. Rejection of a $1.2 billion takeover bid by an activist investor opens path to higher offers or strategic shifts that could alter company trajectory and stock performance.

24 Aug

4 , 1:30 PM
Ancora reaffirms offer to acquire H.B. Fuller’s BAS segment. Reaffirmed acquisition offer for BAS segment signals major strategic shift likely to alter company structure and performance.

3 , 1:47 PM
H.B. Fuller rejects Ancora's $1.2 billion offer for its building adhesives business. Rejection of major divestiture bid preserves unit but blocks large cash inflow and strategic shift.

3 investorshub.advfn.com, 8:50 AM
H.B. Fuller's board rejected Ancora's $1.2 billion bid for the adhesives business, leaving shares unchanged. Rejection of major bid for core adhesives unit leaves operations and valuation unchanged.

14 Aug

4 , 7:30 AM
Engine Capital urges H.B. Fuller board to engage with Ancora on proposal for adhesives business. Activist push for adhesives business engagement signals potential major strategic restructuring.

4 , 7:00 AM
Engine Capital urges H.B. Fuller’s board to run a market check for the Building Adhesive Solutions Segment and the entire company. Activist investor demand for a market check on a core segment and the full company signals potential sale process or major restructuring that would shift strategy and valuation.

4 www.medtechdive.com, 6:00 AM
AMS shareholders approved the company's sale to H.B. Fuller. Acquisition of AMS marks a major strategic expansion for H.B. Fuller.

3 , 11:11 AM
H.B. Fuller weighs an offer for its Building Adhesives Unit after receiving an unsolicited approach. Potential divestiture of the building adhesives unit could affect financial performance and operations.

13 Aug

4 , 1:00 PM
H.B. Fuller announced that AMS shareholders approved the proposed acquisition. AMS shareholder approval advances H.B. Fuller's acquisition, positioning it for expanded operations and growth.

12 Aug

4 , 5:31 PM
H.B. Fuller confirms receipt of an unsolicited proposal for its Building Adhesive Solutions Segment. Unsolicited proposal targets a core segment and may trigger divestiture or strategic overhaul with lasting financial effects.

4 , 9:30 AM
Ancora Holdings Group submits proposal to acquire H.B. Fuller’s Building Adhesive Solutions Segment for $1.1 billion to $1.2 billion in cash. Proposed divestiture of major segment for over one billion dollars constitutes significant strategic move likely to alter company trajectory and finances.

3 , 3:12 PM
Ancora remains comfortable with its offer for a unit of H.B. Fuller Company (FUL). Offer for a company unit may moderately affect specific operations without fundamentally altering overall trajectory.

26 Jul

3 , 7:10 AM
H.B. Fuller completed debt refinance, leaving the stock potentially 24% undervalued. Debt refinance strengthens balance sheet and supports revised valuation outlook.

9 Jul

3 , 8:09 AM
H.B. Fuller Company shares advance on strength in medical and aerospace end-markets plus favorable pricing actions that support margins and revenue growth. Exposure to expanding medical and aerospace demand plus pricing power can lift revenue and margins but does not signal transformative change.

3 , 8:04 AM
H.B. Fuller's stock outlook depends on margins, product mix optimization and M&A activity. Margins, mix shifts and M&A moves can moderately affect financial results and positioning but remain balanced by other factors.

8 Jul

3 www.trefis.com, 7:38 AM
Specialty chemicals maker Innospec is exploring strategic sale options, with H.B. Fuller positioned as a potential buyer amid sector consolidation talks that could reshape competitive dynamics for adhesives and performance chemicals players. Potential Innospec acquisition by FUL or rivals could moderately shift market share and growth opportunities in overlapping specialty chemicals segments.

30 Jun

3 , 4:22 AM
H.B. Fuller Q2 earnings call addressed pricing strategies and outlined ambitions for AMS growth. Q2 earnings call details on pricing and AMS plans indicate potential moderate effects on financials and positioning.

25 Jun

4 transcript GuruFocus.com, 7:00 PM
H.B. Fuller Co reported strong revenue growth in Q2 2026 alongside strategic initiatives during its earnings call. Strong revenue growth reported in earnings call signals major positive shift in financial trajectory and investor sentiment.

4 www.medicaldevice-network.com, 7:43 AM
Advanced Medical Solutions considers £715m takeover bid for H.B. Fuller. Potential £715m takeover bid represents major strategic development that could significantly alter company ownership and trajectory.

4 Investing.com, 4:17 AM
H.B. Fuller acquires Advanced Medical Solutions for £715 million, triggering a 16% surge in AMS shares. The £715 million acquisition marks a major strategic expansion that will reshape H.B. Fuller's operations and market reach.

4 Business Wire, 2:10 AM
H.B. Fuller announces offer to acquire Advanced Medical Solutions. Acquisition offer marks major strategic expansion into medical solutions sector.

3 transcript app.moby.co, 8:30 AM
H.B. Fuller Company discussed its Q2 2026 financial results, performance metrics, and outlook during the earnings call. Quarterly earnings data can moderately shift investor views on financial health and near-term trajectory.

3 Business Wire, 8:30 AM
Ancora condemns H.B. Fuller for ignoring shareholder opposition and proceeding with the acquisition of Advanced Medical Solutions, calling the move reckless. Activist opposition to a major acquisition may pressure H.B. Fuller and affect short-term investor sentiment around the deal.

3 stocktwits.com, 7:08 AM
H.B. Fuller projects $55M synergies from AMS acquisition while investors continue selling FUL shares. AMS deal synergies indicate moderate strategic upside yet investor selling limits immediate market impact.

24 Jun

3 Business Wire, 4:05 PM
H.B. Fuller Company reported second quarter 2026 results. Quarterly earnings releases deliver financial metrics that typically produce moderate effects on near-term stock movement and sentiment.

17 Jun

3 , 3:02 PM
UBS analysts forecast H.B. Fuller will exceed Q2 earnings estimates and may raise full-year guidance. UBS earnings beat forecast and potential guidance raise point to improved near-term financial results and sentiment for H.B. Fuller.

15 Jun

3 , 1:25 PM
H.B. Fuller sets 2030 sustainability targets and directs nearly 60% of innovation toward sustainable solutions. Sustainability targets and innovation focus may moderately enhance long-term market positioning without fundamentally altering operations.

2 Jun

3 Zacks, 9:49 AM
H. B. Fuller Company (FUL) expands its sustainable packaging portfolio with VerdaFresh. VerdaFresh launch adds to FUL sustainable packaging options and supports product innovation.

28 May

3 Business Wire, 11:27 AM
H.B. Fuller launches VerdaFresh advanced oxygen barrier technology to enhance sustainable packaging and barrier coating solutions. New VerdaFresh technology supports product innovation and competitive positioning in sustainable packaging.

26 May

3 Business Wire, 4:01 PM
H.B. Fuller Company issued a statement on its value creation strategy. Value creation strategy statement can moderately shape investor views and near-term stock moves.
© 2016–2026 stockrow.com Terms and Conditions Indicators Weekly Summary Contact Us